Epidemiology of HIV-associated cryptococcosis in France (1985-2001):: comparison of the pre- and post-HAART eras

被引:137
作者
Dromer, F [1 ]
Mathoulin-Pélissier, S
Fontanet, A
Ronin, O
Dupont, B
Lortholary, O
机构
[1] Inst Pasteur, Unite Mycol Mol, Ctr Natl Reference Mycol & Antifongiques, F-75724 Paris, France
[2] Inst Bergonie, Serv Biostat, Bordeaux, France
[3] Inst Pasteur, Unite Epidemiol Malades Emergentes, F-75724 Paris, France
[4] Hop Necker Enfants Malad, Serv Malades Infectieuses & Trop, Paris, France
关键词
cryptococcosis; epidemiology; HAART; Cryptococcus neoformans; HIV; AIDS;
D O I
10.1097/00002030-200402200-00024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To analyse the epidemiological evolution of cryptococcosis in France after the introduction of highly active antiretroviral therapy (HAART). Design: Retrospective study of cryptococcosis cases recorded at the National Reference Center for Mycoses in France since 1985. Methods: Using the national surveillance data, we reviewed 1644 cases of HIV-associated cryptococcosis diagnosed in France (population, 59 million) between 1985 and 2001 and compared them to 335 cases recorded in HIV-negative patients. Results: The total number of cryptococcosis cases evolved in parallel to that recorded for HIV-infected patients. Changes occurring after HAART introduction were analysed. A negative binomial regression model established a 46% decrease of the incidence of cryptococcosis during the post-HAART era (1997-2001, n = 292) compared to the pre-HAART era (1985-1996, n = 1352). According to multivariate analysis, African origin, older age, heterosexual HIV contamination, no previous AIDS-defining illness, and no previous HIV infection diagnosis were variables independently associated with an increased risk of cryptococcosis during the post-HAART era. During the same period, the characteristics of the HIV-negative population did not change. Conclusions: Our analysis of the national surveillance identified demographic factors associated with an increased risk of cryptococcosis in the post-HAART era suggesting that failure to consult and considering oneself not at risk were determinant in the current epidemiology of HIV-related cryptococcosis in France. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:555 / 562
页数:8
相关论文
共 41 条
  • [1] EXPANDED EUROPEAN AIDS CASE DEFINITION
    ANCELLEPARK, R
    [J]. LANCET, 1993, 341 (8842) : 441 - 441
  • [2] [Anonymous], 1992, MMWR Recomm Rep, V41, P1
  • [3] Cryptococcus neoformans infection in a cohort of Italian AIDS patients:: Natural history, early prognostic parameters, and autopsy findings
    Antinori, S
    Galimberti, L
    Magni, C
    Casella, A
    Vago, L
    Mainini, F
    Piazza, M
    Nebuloni, M
    Fasan, M
    Bonaccorso, C
    Vigevani, GM
    Cargnel, A
    Moroni, M
    Ridolfo, A
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (10) : 711 - 717
  • [4] INCIDENCE OF CLINICAL AIDS CONDITIONS IN A COHORT OF HOMOSEXUAL MEN WITH CD4(+) CELL COUNTS LESS-THAN-100/MM(3)
    BACELLAR, H
    MUNOZ, A
    HOOVER, DR
    PHAIR, JP
    BESLEY, DR
    KINGSLEY, LA
    VERMUND, SH
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) : 1284 - 1287
  • [5] Rare AIDS-defining diseases in the Swiss HIV Cohort Study
    Burckhardt, B
    Sendi, P
    Pfluger, D
    Zimmerli, W
    Nüesch, R
    Bucher, HC
    Drewe, J
    Gyr, N
    Battegay, M
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (06) : 399 - 402
  • [6] *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P592
  • [7] Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand
    Chen, S
    Sorrell, T
    Nimmo, G
    Speed, B
    Currie, B
    Ellis, D
    Marriott, D
    Pfeiffer, T
    Parr, D
    Byth, K
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) : 499 - 508
  • [8] Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B
    Chen, SCA
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 : 57 - 61
  • [9] Morbidity and mortality in South African gold miners: Impact of untreated disease due to human immunodeficiency virus
    Corbett, EL
    Churchyard, GJ
    Charalambos, S
    Samb, B
    Moloi, V
    Clayton, TC
    Grant, AD
    Murray, J
    Hayes, RJ
    De Cock, KM
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (09) : 1251 - 1258
  • [10] ESTIMATION OF THE PREVALENCE OF CRYPTOCOCCAL INFECTION AMONG PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS IN NEW-YORK-CITY
    CURRIE, BP
    CASADEVALL, A
    [J]. CLINICAL INFECTIOUS DISEASES, 1994, 19 (06) : 1029 - 1033